Pharmasset Reports Fiscal First Quarter 2009 Financi...( PHARMASSE...)

Date:2/9/2009

PHARMASSET, INC. CONDENSED BALANCE SHEET (UNAUDITED) As of December 31, As of 2008 September 30, (unaudited) 2008 ----------- ---- ASSETS CURRENT ASSETS: Cash and cash equivalents $51,315,887 $63,073,103 Short-term investments 498,467 497,310 Amounts due from collaboration partner 906,072 1,169,690 Prepaid expenses and other assets 641,465 1,008,083 ------- --------- Total current assets 53,361,891 65,748,186 ---------- ---------- EQUIPMENT AND LEASEHOLD IMPROVEMENTS: Laboratory, office furniture and equipment 3,541,633 3,362,846 Leasehold improvements 1,836,553 1,836,553 --------- --------- 5,378,186 5,199,399 Less accumulated depreciation and amortization (2,681,396) (2,432,325) ---------- ---------- Total equipment and leasehold improvements, net 2,696,790 2,767,074 OTHER ASSETS 456,377 466,809 ------- ------- TOTAL $56,515,058 $68,982,069 =
'/>"/>

SOURCE Pharmasset, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8
Related biology technology :

1. Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock
2. Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients
3. Pharmasset to Present at Two Upcoming Investor Conferences
4. Pharmasset to Present at the Natixis Bleichroeder Hidden Gems Conference on Monday, October 13th
5. Pharmasset to Present at the JMP Securities Healthcare Focus Conference on Monday, October 6th
6. Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders
7. Pharmasset to Present at the Upcoming Citibank and Morgan Stanley Investor Conferences
8. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
9. Pharmasset Announces $25.9 Million Registered Direct Offering of Common Stock
10. Pharmasset Joins Russell 3000 Index
11. Pharmasset to Present at the Needham & Co. Biotechnology and Medical Technology Conference on Wednesday, June 11th